What is the share price of EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374)?

Company share prices are keep on changing according to the market conditions. The current trading price of EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of EPIC Enzymes Pharmaceuticals & Indl. Chemicals?

The latest standalone P/E ratio of EPIC Enzymes Pharmaceuticals & Indl. Chemicals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374)?

The latest standalone P/B ratio of EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374) as of 01-Jan-1970 is -0.08.

What is the 52-week high and low of EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374)?

The 52-week high of EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374) is Rs. 1.87 and the 52-week low is Rs. 1.71.

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374)
Brand: EPIC Enzymes Pharmaceuticals & Indl. Chemicals

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374)

BSE: 524374 NSE:

Key Metrics

Market Cap

₹1 Cr.

P/E Ratio

0.00

Price to Book (P/B)

-0.08

Price to Sales (P/S)

0.00

EV/EBITDA

-141.75

Return on Capital Employed (ROCE)

-7.67%

Current Price

₹0

Return on Equity (ROE)

0.00%

Return on Assets (ROA)

-4.30%

Operating Profit Margin

Net Profit Margin

-INF%

Gross Profit Margin

Book Value per Share

₹-22.8

Sales Growth (YoY)

-100%

Sales Growth (3 Years)

-100%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹2 / 2

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

27.22%

Pledged shares (%)
of Promoter's holding (%)

0.00%

DeciZen - make an informed investing decision on EPIC Enzymes Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

EPIC Enzymes Pharmaceuticals & Indl. Chemicals stock performance

Key Ratios

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Jun'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	TTM
ROCE % ⓘ	6.9%	10.9%	-0.8%	-9.1%	-9.1%	-25.3%	-10.3%	-4.9%	-100.4%	-7.7%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	13.7	18.3	16.8	11.5	8.6	6.5	1.9	0.1	0.2	0	0
Sales YoY Gr.	-	33.5%	-8%	-31.5%	-25.4%	-24.4%	-70.6%	-93.7%	83.3%	-100%	-
Adj EPS ⓘ	-0.7	0.7	-0.9	-4.1	-7.7	-10.9	-2.4	-1.3	-8.9	-0.3	-0.3
YoY Gr.	-	NA	-227.1%	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	14.4	22.4	15.8	12.5	6.5	-3.7	-6.1	-7.2	-22.7	-22.9	-22.8
Adj Net Profit ⓘ	-0.6	0.6	-0.8	-3.5	-6.6	-9.3	-2.1	-1.1	-7.7	-0.2	-0
Cash Flow from Ops. ⓘ	0.4	1.3	-3	-6.4	-0.9	-3.2	1	-0.2	1.8	-0.9	-
Debt/CF from Ops. ⓘ	26.4	10.2	-4.4	-3.2	-21.6	-7.1	21.4	-100.6	12.7	-24.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	-100%	-100%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	-205.2%	-228.7%	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Jun'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	TTM
Return on Equity % ⓘ	-4.5	3.2	-5.2	-27	-72	-439.2	62.5	22	62.9	1.2	1.2
Op. Profit Mgn % ⓘ	5.7	9.2	-14	-33.5	-48.8	-95.8	-82.8	-476.8	-458.7	0	NAN
Net Profit Mgn % ⓘ	-4.2	3.3	-4.6	-30.6	-77.1	-143.6	-109.8	-938.6	-3445.5	0	-INF
Debt to Equity ⓘ	0.8	0.7	1	1.9	3.6	-7.2	-4.2	-3.6	-1.2	-1.2	-
Working Cap Days ⓘ	217	247	264	438	563	490	779	13,659	6,162	0	0
Cash Conv. Cycle ⓘ	35	58	93	182	323	347	423	5,013	1,448	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0.3	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹) ⓘ	-22.8	-
Reserves (₹ Cr.) ⓘ	-28	-
P/BV ⓘ	-0.08	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	1.71 / 1.87
All Time Low / High (₹)	1.43 / 82.40
Market Cap (₹ Cr.)	1.5
Equity (₹ Cr.)	8.6
Face Value (₹)	10
Industry PE ⓘ	27.7

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of EPIC Enzymes Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Jun'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Sales	13.70	13.71	16.83	11.53	8.60	6.50	1.91	0.12	0.22	0
Operating Expenses ⓘ +	12.93	12.45	19.19	15.43	12.79	12.84	3.54	0.67	1.24	0.18
Manufacturing Costs	2.54	2.22	3.16	2.34	1.46	1.51	0.44	0.12	0	0
Material Costs	7.45	7.53	13.08	9.96	5.28	10.17	2.11	0.22	0.99	0
Employee Cost	1.12	0.74	1.11	1.31	0.49	0.19	0.13	0.06	0.01	0
Other Costs ⓘ	1.81	1.97	1.83	1.81	5.57	0.96	0.86	0.28	0.23	0.18
Operating Profit ⓘ	0.78	1.26	-2.36	-3.89	-4.20	-6.34	-1.63	-0.55	-1.02	-0.18
Operating Profit Margin (%)	5.7%	9.2%	-14.0%	-33.8%	-48.8%	-97.4%	-85.4%	-476.0%	-458.0%	-
Other Income ⓘ +	1.51	2.24	3.07	2.01	2.40	1.31	0.20	0.13	2.02	0.01
Exceptional Items ⓘ	0	0	0	0	0	0	-0.01	0.03	-10.42	0
Interest ⓘ	1.15	0.79	1.15	1.35	1.56	3.14	0.28	0.27	4.56	0
Depreciation ⓘ	0.82	0.95	0.91	0.78	0.78	0.65	0.42	0.41	0.06	0.06
Profit Before Tax ⓘ	0.32	1.76	-1.36	-4.01	-4.14	-8.81	-2.13	-1.07	-14.03	-0.23
Tax ⓘ	0	-0.11	-0.59	-1.62	1.19	0.01	0	0	0	0
Profit After Tax	0.32	1.86	-0.77	-2.39	-5.33	-8.82	-2.14	-1.07	-14.03	-0.23
PAT Margin (%)	2.3%	13.6%	-4.6%	-20.7%	-62.0%	-135.0%	-112.0%	-918.0%	-6,322.1%	-
Adjusted EPS (₹)	0.4	2.2	-0.9	-2.8	-6.2	-10.3	-2.5	-1.2	-16.4	-0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Jun'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Equity and Liabilities
Shareholders Fund +	13.16	15.03	14.25	11.86	6.53	-2.28	-4.42	-5.49	-18.81	-19.04
Share Capital ⓘ	8.57	8.57	8.57	8.57	8.57	8.57	8.57	8.57	8.57	8.57
Reserves ⓘ	4.59	6.46	5.68	3.29	-2.04	-10.85	-12.99	-14.06	-27.38	-27.61
Debt +	10.20	9.56	13.34	20.75	19.89	22.51	21.91	22.14	22.34	22.63
Long Term Debt	10.20	9.56	13.34	20.75	19.89	22.51	21.91	22.14	22.34	22.63
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	4.59	3.99	6.32	4.37	2.64	0.99	0.99	0.99	1.69	1.58
Others Liabilities ⓘ	1.27	1.88	0.47	-1.02	0.47	0.97	0.80	3.99	0.11	0.11
Total Liabilities ⓘ	29.21	30.45	34.38	35.96	29.53	22.19	19.28	21.65	5.34	5.28
Fixed Assets
Net Fixed Assets ⓘ +	17.80	17.35	16.75	15.94	16.27	15.62	15.19	14.78	1.40	1.34
Gross Block	26.47	26.93	27.24	27.16	28.27	28.27	28.24	28.24	2	2
Accumulated Depreciation	8.67	9.58	10.49	11.22	12.01	12.65	13.05	13.46	0.60	0.66
CWIP ⓘ	0.14	0	0	1.11	0	0	0	0	0.40	0.40
Investments ⓘ	0.13	0.13	0.13	0.13	0.12	0.12	0.40	0.12	0.12	0.12
Inventories	5.75	6.39	10.26	10.66	7.74	2.49	1.87	1.65	0.67	0.67
Trade Receivables	0.74	1.13	0.56	1.86	2.17	1.87	0.04	0.17	0.02	0.01
Cash Equivalents	2.18	2.29	2.61	2.58	0.72	0.20	0.07	0.08	0.92	0.28
Others Assets ⓘ	2.47	3.17	4.08	3.69	2.52	1.88	1.70	4.84	1.80	2.45
Total Assets ⓘ	29.21	30.45	34.38	35.96	29.53	22.19	19.28	21.65	5.34	5.28

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Jun'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Cash Flow From Operating Activity ⓘ +	0.39	0.94	-3	-6.41	-0.92	-3.16	1.02	-0.22	1.76	-0.94
PBT ⓘ	0.32	1.75	-1.36	-4.02	0.20	-8.81	-2.12	-1.07	-3.61	-0.23
Adjustment ⓘ	1.48	1.40	1.82	2.36	2.37	3.89	0.77	0.41	4.67	0.12
Changes in Working Capital ⓘ	-0.75	-1.65	-2.63	-2.67	3.6	4.9	2.38	0.08	0.7	-0.83
Tax Paid ⓘ	0	-0.11	-0	-0.01	-0.02	-0.01	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-0.38	-0.20	-0.47	-1.02	0.16	0.01	-0.27	0	-2.65	0.01
Capex	-0.26	-0.36	-0.31	-1.17	-0	-0	0	0	-2.67	0
Net Investments	-0.31	0	-0.29	0	0	-0.02	-0.27	0	0	0
Others ⓘ	0.19	0.15	0.14	0.15	0.17	0.03	0	0	0.02	0.01
Cash Flow From Financing Activity ⓘ +	1.72	-0.64	3.79	7.41	-1.11	2.62	-0.87	0.23	1.60	0.28
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	-0.64	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	1.72	0	3.79	7.41	-1.11	2.62	-0.87	0.23	1.60	0.28
Net Cash Flow ⓘ	1.73	0.10	0.32	-0.03	-1.86	-0.53	-0.12	0.01	0.71	-0.64

Finance Ratio

PARTICULARS	Jun'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Ratios
ROE (%)	2.61	13.94	-5.52	-19.75	-65.6	N/A	N/A	N/A	N/A	N/A
ROCE (%)	6.85	10.94	-0.81	-9.12	-9.05	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0.5	0.47	0.53	0.35	0.27	0.25	0.1	0.01	0.02	0
PAT to CFO Conversion(x)	1.22	0.51	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	28.20	24.50	18	35.40	83.40	113.30	167.90	301	135.40	0
Inventory Days	141.30	159.20	176.80	306.70	381.70	286.70	382	5,090.90	1,692.10	0
Payable Days	238.40	207.90	143.80	195.70	242.10	65.10	171.40	1,647.40	433	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd FAQs

The current trading price of EPIC Enzymes Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of EPIC Enzymes Pharma stood at ₹1.47 Cr

The latest P/E ratio of EPIC Enzymes Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of EPIC Enzymes Pharma as of 31-Dec-1969 is -0.08.

The 52-week high of EPIC Enzymes Pharma is ₹1.87 and the 52-week low is ₹1.71.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EPIC Enzymes Pharma is ₹0.00 ( Cr.) .

About EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd

Epic Enzymes Pharmaceuticals & Industrial Chemicals was incorporated on November 2, 1982 under the Companies Act in 1956 in Maharashtra as a private limited company, which was converted to a public limited company on November 6, 1992, by a special resolution of the general meeting of the company. The company was originally promoted by Ratanshaw Elavia and K N Nikorawalla. The company has entered into a technical and financial collaboration with Feinchemie Schewebda GmbH.

Epic Enzymes specialises in organic chemicals, pesticides and herbicides. The company`s registered office is located in Vashi, Navi Mumbai, Maharashtra. Its factory is located at Plot No. 32, VRDIC, Vithoba Industrial Complex, Village Lohop, post Mazgaon, taluka Khalapur, district Raigad, Maharashtra. Installed capacity of the company is 800 MT per annum.

Business areas of the company:

The company is engaged in the agrochemical business. The agrochemical industry consists of various products in different segments like insecticides, fungicides, weedicides, herbicides, and rodenticides. Raw materials that are used to manufacture agrochemicals are food grains and commercial crops.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd (524374) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating